[ad_1]
Sometimes this disease was synonymous with disability in teak. Today, this is no longer the case, thanks to controlled treatment. However, in Serbia, however, treatment is only available for 12% of MS patients.
Prof. pie Dr Dragana Obradovi, PhD, neurologist specialist
Source: B92, weekly
Photo: designer491 / depositphotos
This is your first association to mention multiple sclerosis? A young person in a wheelchair … Sadness and helplessness. And you'd be a little right because it was a picture of multiple sclerosis 30, 40 or 50 years ago. This is found in neurological diseases of young people and the leading cause of disability in young people. The basis of the disease is the immune response, which leads to the loss of its own nerve fibers, the formation of brain and kerosene lesions and the appearance of many different symptoms (visual disturbances, vertigo, sensitivity and / or weakness of arms and legs, body tension, urinary disorders …). . If the illness does not lie, it will eventually lead to disability. And that's the picture of the second sentence of this text. Half of patients who have been ill for 20 years with the disease have been on tap for 30 years in a wheelchair. If you get sick at 20, that is, in the best years, you walk with a 40-year-old faucet, that is, Lina and her family and a social disaster.
However, everything has changed in the last 20 years with the emergence of a therapy that modifies the evolution of the disease, that is, that acts on the altered immune mechanisms, removes them and allows the disease to derive under control. This means that there is no new involvement of the nervous system, the neurological status of patients does not progress, but the disease stops, keeps up. It allows people to live a normal, quality life – they ride their bikes, they grow up, they start a family. Some 15 original drugs are available today. The reason for this number of drugs is that multiple sclerosis, or multiple sclerosis, is very different.
Photo: ChiccoDodiFC / Depositphotos
In some diseases, the flow can be mild, and at some of its beginnings it can be very aggressive and lead quickly to disability. The aggressiveness of the disease involves the aesthetic clinical exacerbation and the occurrence of a large number of new brain and kidney abnormalities monitored by magnetic resonance examination. So we have moderate-activity drugs, middle and high-potency drugs. Because of this diversity, we are talking about personalized treatment for MS, that is, today, depending on the patient and the activities of his disease, choose a drug that in each case will be the more efficient. By therapy, we want to achieve lasting remission, that is, the patient does not have a new disease, his or her neurological deficit is unchanged or even better than the therapy, and there is no new condition brainwashing or chemotherapy. The international consensus of experts has determined that treatment should begin no later than three months after diagnosis. The early onset of treatment means the application of treatment in the period when it is most effective and where patients do not always have significant complications. Early and well-chosen treatment can control the disease.
Is this disease incurable, or should the story be treatment-controlled therapy? After all, is diabetes curable? This is not the case, but the therapy is under control and thanks to it, people lead a normal life.
In Serbia, treatment is only available for 12% of patients with MS and for four medications of moderate activity.
It is time to change the stigma and ensure the availability of treatment to all patients with multiple sclerosis. Because the right to health is a basic human right. The right to health means the right to look.
[ad_2]
Source link
